[Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
作者信息
Kozulicyna T I, Korotajev G A
出版信息
G Ital Chemioter. 1972 Jan-Jun;19(2):7-10.
PMID:4199030
Abstract
摘要
相似文献
1
[Experimental in-vitro and in-vivo studies of the antibacterial effect of rifampicin and ethambutol].
G Ital Chemioter. 1972 Jan-Jun;19(2):7-10.
2
3
[Question of bactericidal effect of a combination of maximally tolerable doses of INH, Myambutol and Rifadin on experimental tuberculosis].
Plucne Bolesti Tuberk. 1973 Jul-Dec;25(3):251-6.
4
[Survival of tuberculous bacilli in combined treatments including rifampicin].[结核杆菌在含利福平联合治疗中的存活情况]
Rev Tuberc Pneumol (Paris). 1970 Apr-May;34(3):429-33.
5
Correlation of in vitro and in vivo kinetics with clinical use of isoniazid, ethambutol, and rifampin.异烟肼、乙胺丁醇和利福平的体外及体内动力学与临床应用的相关性。
Am Rev Respir Dis. 1973 Jun;107(6):1013-21. doi: 10.1164/arrd.1973.107.6.1013.
6
Bactericidal activity in vitro and in the guinea-pig of isoniazid, rifampicin and ethambutol.异烟肼、利福平及乙胺丁醇在体外和豚鼠体内的杀菌活性。
Tubercle. 1976 Dec;57(4):251-8. doi: 10.1016/s0041-3879(76)80002-5.
7
Primary and acquired drug resistance in Mycobacterium tuberculosis strains in western region of Libyan Arab Jamahiriya.阿拉伯利比亚民众国西部地区结核分枝杆菌菌株的原发性和获得性耐药性
Trop Geogr Med. 1989 Oct;41(4):304-8.
8
The use of in-vitro and in-vivo experiments with Mycobacterium tuberculosis in helping to plan chemotherapy regimens.利用结核分枝杆菌的体外和体内实验来协助制定化疗方案。
Tidsskr Nor Laegeforen. 1975 Jun 20;95(17-18):1087-9.
9
Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).德里结核病的耐药性：两年概况（2001 - 2002年）
J Commun Dis. 2003 Jun;35(2):74-81.
10
[Sensitivity to rifampicin and ethambutol of mycobacteria resistant to isoniazid or streptomycin].[对异烟肼或链霉素耐药的分枝杆菌对利福平和乙胺丁醇的敏感性]
G Ital Chemioter. 1972 Jan-Jun;19(2):20-2.
Zotero 插件